Gelidium amansii extract ameliorates obesity by down-regulating adipogenic transcription factors in diet-induced obese mice

키워드

참고문헌 (51)

1. Nieves JW, "Calcium potentiates the effect of estrogen and calcitonin on bone mass: Review and analysis", Am. J. Clin. Nutr, 67, pp.18~24 (1998)
2. Kopelman PG, "Obesity as a medical problem", Nature, 404, pp.635~643 (2000)
3. Wang T, "Evodiamine improves diet-induced obesity in a uncoupling protein-1-independent manner: involvement of antiadipogenic mechanism and extracellularly regulated kinase", mitogen-activated protein kinase signaling, 2008, pp.149, 358~366
4. Choi H, "A water-soluble extract from Cucurbita moschata shows anti-obesity effects by controlling lipid metabolism in a high fat diet-induced obesity mouse model", Biochem Biophys Res Commun, 359, pp.419~425 (2007)
5. Giri S, "AICAR inhibits adipocyte differentiation in 3T3L1 and restores metabolic alterations in diet-induced obesity mice model", Nutr Metab (Lond), 3, pp.31~ (2006)
6. Rosen ED, "Transcriptional regulation of adipogenesis", Genes Dev, 14, pp.1293~1307 (2000)
7. Sztalryd C, "Regulation of hormone-sensitive lipase in streptozotocin-induced diabetic rats", Metabolism, 44, pp.1391~1396 (1995)
8. Lefterova MI, "New developments in adipogenesis", Trends Endocrinol Metab, 20, pp.107~114 (2009)
9. Wasan KM, "Emerging pharmacological approaches to the treatment of obesity", J Pharm Pharm Sci, 8, pp.259~271 (2005)
10. Lee YS, "Effects of a Citrus depressa Hayata (shiikuwasa) extract on obesity in high-fat diet-induced obese mice", Phytomedicine, 18, pp.648~654 (2011)
11. Hofbauer KG, "Pharmacotherapy of obesity", Exp Clin Endocrinol Diabetes, 114, pp.475~484 (2006)
12. Bray GA, "Medical therapy for obesity", Mt Sinai J Med, 77, pp.407~417 (2010)
13. Choi KM, "Green tomato extract attenuates high-fat-diet-induced obesity through activation of the AMPK pathway in C57BL", 6 mice, 2013, pp.24, 335~342
14. Kadam SU, "Marine foods as functional ingredients in bakery and pasta products", Food Res Int, 43, pp.1975~1980 (2010)
15. Yan X, "Antioxidative activities in some common seaweeds", Plant Foods Hum Nutr, 52, pp.253~262 (1998)
16. Fu YW, "The immunostimulatory effects of hot-water extract of Gelidium amansii via immersion, injection and dietary administrations on white shrimp Litopenaeus vannamei and its resistance against Vibrio alginolyticus", Fish Shellfish Immunol, 22, pp.673~685 (2007)
17. Yuan H, "Immunomodulation and antitumor activity of kappa-carrageenan oligosaccharides", Cancer Lett, 243, pp.228~234 (2006)
18. Kang MC, "Popular edible seaweed, Gelidium amansii prevents against diet-induced obesity", Food Chem Toxicol, 90, pp.181~187 (2016)
19. Friedewald WT, "Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge", Clin Chem, 18, pp.499~502 (1972)
20. Folch J, "A simple method for the isolation and purification of total lipides from animal tissues", J Biol Chem, 226, pp.497~509 (1957)
21. Yamashita Y, "Prevention mechanisms of glucose intolerance and obesity by cacao liquor procyanidin extract in high-fat diet-fed C57BL", 6 mice, 2012, pp.527, 95~104
22. Lee J, "Regulation of obesity and lipid disorders by herbal extracts from Morus alba, Melissa officinalis, and Artemisia capillaris in high-fat diet-induced obese mice", J Ethnopharmacol, 115, pp.263~270 (2008)
23. 서민정, "Extract from Edible Red Seaweed (Gelidium amansii) Inhibits Lipid Accumulation and ROS Production during Differentiation in 3T3-L1 Cells", Preventive Nutrition and Food Science, 17(2), pp.129~135 (2012), 한국식품영양과학회[DOI]
24. Hokanson JE, "Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies", J Cardiovasc Risk, 3, pp.213~219 (1996)
25. Miller M, "Triglycerides and cardiovascular disease:a scientific statement from the American Heart Association", Circulation, 123, pp.2292~2333 (2011)
26. den Boer M, "Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models", Arterioscler Thromb Vasc Biol, 24, pp.644~649 (2004)
27. Ferri M, "Recovery of polyphenols from red grape pomace and assessment of their antioxidant and anti-cholesterol activities", N Biotechnol, 33, pp.338~344 (2016)
28. He ML, "Effect of a seaweed extract on fatty acid accumulation and glycerol-3- phosphate dehydrogenase activity in 3T3-L1 adipocytes", Lipids, 44, pp.125~132 (2009)
29. Körner A, "Obesity in childhood and adolescence: a review in the interface between adipocyte physiology and clinical challenges", Hormones(Athens), 4, pp.189~199 (2005)
30. Staiger H, "Relationship of serum adiponectin and leptin concentrations with body fat distribution in humans", Obes Res, 11, pp.368~372 (2003)
31. Jéquier E., "Leptin signaling, adiposity, and energy balance", Ann N Y Acad Sci, 967, pp.379~388 (2002)
32. Lee Y, "Liporegulation in diet-induced obesity. The antisteatotic role of hyperleptinemia", J Biol Chem, 276, pp.5629~5635 (2001)
33. Wu X, "Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes", Diabetes, 52, pp.1355~1363 (2003)
34. Hu E, "AdipoQ is a novel adipose-specific gene dysregulated in obesity", J Biol Chem, 271, pp.10697~10703 (1996)
35. Siegrist M, "Leptin, adiponectin, and short-term and long-term weight loss after a lifestyle intervention in obese children", Nutrition, 29, pp.851~857 (2013)
36. Bruun JM, "Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans", Am J Physiol Endocrinol Metab, 285, pp.E527~E533 (2003)
37. Park J, "Overexpression of glucose-6-phosphate dehydrogenase is associated with lipid dysregulation and insulin resistance in obesity", Mol Cell Biol, 25, pp.5146~5157 (2005)
38. Schoonjans, K., "The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation", Biochim. Biophys. Acta, 1302, pp.93~109 (1996)
39. Rosen ED, "C", EBPalpha induces adipogenesis through PPARgamma: a unified pathway, 2002, pp.16, 22~26
40. Kamei R, "Shikonin stimulates glucose uptake in 3T3-L1adipocytes via an insulin-independent tyrosine kinase pathway", Biochem Biophys Res Commun, 292, pp.642~651 (2002)
41. Kim JB, "ADD1", SREBP1activates PPARgamma through the production of endogenous ligand, 1998, pp.95, 4333~4337
42. Evans RM, "PPARs and the complex journey to obesity", Nat Med, 10, pp.355~361 (2004)
43. Wang S, "Novel insights of dietary polyphenols and obesity", J Nutr Biochem, 25, pp.1~18 (2014)
44. Mohammed A, "Docking studies on the interaction of flavonoids with fat mass and obesity associated protein", Pak J Pharm Sci, 28, pp.1647~1653 (2015)
45. Zhang BB, "AMPK: an emerging drug target for diabetes and the metabolic syndrome", Cell Metab, 9, pp.407~416 (2009)
46. Jung HA, "Phlorotannins isolated from the edible brown alga Ecklonia stolonifera exert anti-adipogenic activity on 3T3-L1 adipocytes by downregulating C", EBPα and PPARγ, 2014, pp.92, 260~269
47. Vingtdeux V, "Small-molecule activators of AMP-activated protein kinase (AMPK), RSVA314 and RSVA405, inhibit adipogenesis", Mol Med, 17, pp.1022~1030 (2011)
48. Hardie DG, "AMPK: a key regulator of energy balance in the single cell and the whole organism", Int J Obes, 32(Suppl 4), pp.S7~S12 (2008)
49. Watt MJ, "Regulation of HSL serine phosphorylation in skeletal muscle and adipose tissue", Am J Physiol Endocrinol Metab, 290, pp.E500~E508 (2006)
50. Bezaire V, "Contribution of adipose triglyceride lipase and hormone-sensitive lipase to lipolysis in hMADS adipocytes", J Biol Chem, 284, pp.18282~18291 (2009)
51. Son Y, "Antiobesity activity of Vigna nakashimae extract in high-fat diet-induced obesity", Biosci Biotechnol Biochem, 77, pp.332~338 (2013)

관련 논문AI추천